Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dilute vs Standard Heparin for CRRT Anticoagulation
NCT01318811Phase 4Terminated
- Sponsor
- Vanderbilt University
- Start
- Mar 2011
- Primary completion
- Apr 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of heparin in acute kidney injury (AKI), heart failure (HF), sponsored by Vanderbilt University. Started Mar 2011; status: terminated.
02
Drugs
heparin
03
Conditions
acute kidney injury (AKI)heart failure (HF)
Beyond the preview
Go deeper on NCT01318811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01318811.